Effects on androgen receptor nuclear import by docetaxel, cabazitaxel, abiraterone, and enzalutamide: Potential mechanism for cross-resistance in castration-resistant prostate cancer (CRPC).
Robert J. van Soest
No relevant relationships to disclose
Martin E. van Royen
No relevant relationships to disclose
Ellen S. de Morrée
No relevant relationships to disclose
Erik A.C. Wiemer
No relevant relationships to disclose
Ron H.J. Mathijssen
Research Funding - Sanofi
Ronald De Wit
Consultant or Advisory Role - Sanofi
Honoraria - Sanofi
Research Funding - Sanofi
Wytske M. van Weerden
No relevant relationships to disclose